COMMUNIQUÉS West-GlobeNewswire

-
NMDP BioTherapies Appoints New President to Lead Next Phase in Life-Saving Therapy Development
30/01/2024 -
60 Degrees Pharmaceuticals Announces Pricing of $2.4 Million Public Offering
30/01/2024 -
Aeroflow Health Announces New Leadership Appointments Amid Company Growth
30/01/2024 -
UTMD Reports Audited Year 2023 and Fourth Quarter Financial Performance
30/01/2024 -
TytoCare to Host Major Health System Leaders for School Health Virtual Summit
30/01/2024 -
Talkspace and Bicycle Health Partner to Expand Access to Virtual Care for Patients with Opioid Use Disorder
30/01/2024 -
CorMedix Inc. Announces Commercial and Reimbursement Updates
30/01/2024 -
SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application
30/01/2024 -
Fingerprint Drug Test Delivers Quantifiable Benefits for Customers as Adoption in Workplaces Accelerates
30/01/2024 -
QHSLab Integrates Digital Medicine Assessments into Prominent Electronic Health Record (EHR) Company
30/01/2024 -
Entera Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
30/01/2024 -
Revolo Biotherapeutics Receives Orphan Drug Designation from the U.S. FDA for its First-in-Class Peptide as a Potential Treatment for Eosinophilic Esophagitis
30/01/2024 -
BioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core Strategy
30/01/2024 -
Huxley Health Inc. Provides Corporate Update - Appoints Bruce Linton as Chairman
30/01/2024 -
Acceptance of Ivospemin (SBP-101) Abstract for Poster Presentation at American Association for Cancer Research (AACR)
30/01/2024 -
Le KFSH&RC-Madinah reçoit le prestigieux prix 2023 Human Experience Guardian of Excellence de Press Ganey
30/01/2024 -
MaxCyte and Wugen Sign Strategic Platform License to Expedite Scale-Up of Clinical and Commercial Manufacturing of Wugen’s Investigational Allogeneic, Off-the-Shelf Cell Therapies for Cancers
30/01/2024 -
Vaxxinity Announces Research Collaboration on Active Immunotherapies for Neurodegenerative Diseases with University of Florida
30/01/2024 -
Aquestive Therapeutics to Participate in Oppenheimer 34th Annual Healthcare Conference
30/01/2024
Pages